Moffitt Cancer Center researchers find MK1775 active against sarcomas
Friday, December 2, 2011 - 17:30
in Health & Medicine
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing...
Read the whole article on Science Blog
More from Science Blog
Related
- Moffitt Cancer Center researchers find more clues to causes of breast cancerThu, 27 Oct 2011, 19:39:27 EDT
- 2-drug combo more effective in treating sarcomas, Moffitt Cancer Center study showsTue, 9 Apr 2013, 19:09:51 EDT
- Moffitt Cancer Center researchers discover how cancer cells 'hijack' a mechanism to growTue, 14 Aug 2012, 11:09:48 EDT
- Moffitt Cancer Center researchers find regulatory T-cell clue to help prevent GVHDMon, 31 Oct 2011, 13:32:06 EDT
- Moffitt researchers find cancer therapies affect cognitive functioning among breast cancer survivorsSat, 21 Apr 2012, 12:39:01 EDT